Advicenne (XPAR:ALDVI) Short-Term Debt : €1.42 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Advicenne Short-Term Debt?

Advicenne's Short-Term Debt for the quarter that ended in Dec. 2023 was €1.42 Mil.

Advicenne's quarterly Short-Term Debt increased from Dec. 2022 (€1.42 Mil) to Jun. 2023 (€1.48 Mil) but then declined from Jun. 2023 (€1.48 Mil) to Dec. 2023 (€1.42 Mil).

Advicenne's annual Short-Term Debt increased from Dec. 2021 (€0.10 Mil) to Dec. 2022 (€1.42 Mil) and increased from Dec. 2022 (€1.42 Mil) to Dec. 2023 (€1.42 Mil).

Advicenne Short-Term Debt Historical Data

The historical data trend for Advicenne's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advicenne Short-Term Debt Chart

Advicenne Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

0.13

4.41

0.10

1.42

Advicenne Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial												0.10	0.29	1.42	1.48	1.42

Advicenne Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Advicenne Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Advicenne's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Advicenne (XPAR:ALDVI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advicenne SA (XPAR:ALDVI) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

3MM:Germany

Address

2, rue Briconnet, Nimes, FRA, F-30 000

Website

http://www.advicenne.com

Advicenne SA is a late-stage biopharmaceutical company. The company is engaged in the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and niche neurology indications. Its goal is to improve the lives of patients from early childhood through adulthood.

Advicenne (XPAR:ALDVI) Headlines

No Headlines